Article
Prognostic role of IDH mutations in gliomas: a meta-analysis of 55 observational studies.
Oncotarget - 10 Jul 2015
Xia Liang, Wu Bin, Fu Zhiquan, Feng Fang, Qiao Enqi, Li Qinglin, Sun Caixing, Ge Minghua
Abstract excerpt
BACKGROUND: IDH (Isocitrate dehydrogenase) mutations occur frequently in gliomas, but their prognostic impact has not been fully assessed. We performed a meta-analysis of the association between IDH mutations and survival in gliomas. METHODS: Pubmed and EMBASE databases were searched for studies reporting IDH mutations (IHD1/2 and IDH1) and survival in gliomas. The primary outcome was overall survival (OS); the...
Read the complete abstract on PubMedTopics
Share this publication in a Topic to start or enrich a Post.
